Neutropenic Fever, Skin and Eye Toxicities Develops During Docetaxel Treatment in Metastatic Prostate Cancer: A Case Report

Üroonkoloji Bülteni
doi 10.4274/uob.908
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Galenos Yayinevi

Related search

Case Report: Responses to Cabazitaxel in Metastatic Castration-Resistant Prostate Cancer After Extensive Docetaxel Treatment

Clinical Genitourinary Cancer
OncologyUrology
2011English

Management of Docetaxel Failures in Metastatic Castrate-Resistant Prostate Cancer

Urologic Clinics of North America
Urology
2012English

Metastatic Prostate Cancer Initially Presenting as Chylothorax: A Case Report

Molecular and Clinical Oncology
Cancer ResearchOncology
2016English

Pcn336 - Treatment of Metastatic Castration-Resistant Prostate Cancer Patients Previously Treated With Docetaxel in Portugal

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

‘Charting a New Course for Prostate Cancer’ – Currying Favor for Docetaxel in Hormone-Sensitive Metastatic Prostate Cancer

Expert Review of Anticancer Therapy
OncologyPharmacology
2014English

Weekly Docetaxel in the Treatment of Metastatic Breast Cancer

Therapeutics and Clinical Risk Management
2008English

Piecing the Puzzle Together: Docetaxel Cycles and Current Considerations in the Treatment of Metastatic Castration-Resistant Prostate Cancer

Cancer Biology and Therapy
Cancer ResearchOncologyMolecular MedicinePharmacology
2017English

Expanding Horizons in Metastatic Prostate Cancer Treatment

Nature Reviews Clinical Oncology
Oncology
2011English

A Case of Metastatic Prostate Cancer and Immune Thrombocytopenia

Current Oncology
Oncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy